Policy

David Tawes, M.A., regional inspector general at HHS-OIG, joins the show to discuss Medicare’s $15 billion skin substitute boom, fraud risks and how policymakers aim to curb abuse without limiting patient care.

A revised CMS notice late on Oct. 15 said claims for Physician Fee Schedule and other payment programs will be processed and paid in a timely manner. The exceptions are claims for programs that have expired, such as telehealth flexibilities.

Jason Jobes of Norwood explains why the move toward value-based care is both necessary and challenging — and what physician practices can do to prepare.

Lawmakers, governor approve bill allowing more scrutiny of health care deals.

The Institute for Healthcare Improvement unveils a four-step framework to help hospitals and practices measure inequities the same way, turning goals into actionable metrics.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

Pfizer was at the White House late last month; AstraZeneca touts expansion in Virginia.

A new KFF survey finds that while 77% of Americans heard President Trump’s claim linking Tylenol use during pregnancy to autism, most aren’t convinced.

A KFF survey shows 77% of U.S. adults heard President Trump’s claim linking Tylenol use in pregnancy to autism. Most don’t believe it.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

Deepika Srivastava of The Doctors Company breaks down how AI is transforming medical malpractice — from shifting standards of care to new liability risks — and what physicians must do now to stay protected.

SullivanCotter’s 2025 survey finds executive compensation up 4.7% overall, with the fastest growth in operations, digital strategy and compliance leadership roles.

In part two of MJH Life Sciences’ three-part series, experts dissect President Trump’s most-favored nation executive order, warning that its use of tariffs and foreign price benchmarks could upend drug markets and test the limits of federal authority.

Deepika Srivastava of The Doctors Company discusses how AI is transforming medicine — and why physicians must stay engaged as the technology evolves.

Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.

Kyle Zebley, senior VP of the American Telemedicine Association, joins the show to talk about the expiration of Medicare’s telehealth flexibilities during the October 2025 federal government shutdown.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

As spending climbs and value plummets, Trilliant Health proposes hard questions to buck negative trends.

Kevin Schulman, M.D., MBA, professor of medicine at Stanford University, joins the show to talk about administrative burdens in health care.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert from the American Telemedicine Association offers his summary of what’s happening in Washington, D.C.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.